chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Oropharyngeal pain, Pain, Pain in extremity, Swelling
Clinical narrative: neck seem to swollen; had a pain on their throat as if had something stucked; pain in the arm increasde up to the point that they could not move it; pain in the arm increasde up to the point that they could not move it; little pain on their arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little pain on their arm), PAIN (pain in the arm increasde up to the point that they could not move it), MOBILITY DECREASED (pain in the arm increasde up to the point that they could not move it), OROPHARYNGEAL PAIN (had a pain on their throat as if had something stucked) and SWELLING (neck seem to swollen) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (little pain on their arm). On 17-Feb-2021, the patient experienced PAIN (pain in the arm increasde up to the point that they could not move it) and MOBILITY DECREASED (pain in the arm increasde up to the point that they could not move it). On 18-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (had a pain on their throat as if had something stucked). On 19-Feb-2021, the patient experienced SWELLING (neck seem to swollen). On 19-Feb-2021, PAIN IN EXTREMITY (little pain on their arm), PAIN (pain in the arm increasde up to the point that they could not move it) and MOBILITY DECREASED (pain in the arm increasde up to the point that they could not move it) had resolved. At the time of the report, OROPHARYNGEAL PAIN (had a pain on their throat as if had something stucked) and SWELLING (neck seem to swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications included thyroid and blood pressure medications Treatment details included none
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine
Clinical narrative: Low level migraine; headache started pretty quickly after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Low level migraine) and HEADACHE (headache started pretty quickly after the first dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L02A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced MIGRAINE (Low level migraine) and HEADACHE (headache started pretty quickly after the first dose). At the time of the report, MIGRAINE (Low level migraine) and HEADACHE (headache started pretty quickly after the first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported.   Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Disturbance in attention, Dizziness, Feeling abnormal
Clinical narrative: arthralgia - sheets soaked in the morning; Did not feel like herself; felt really sick; Felt nauseous; Chills; Vaccination site pain; Felt like she was going to faint/Felt dizzy all day; Head was spinning in circles; Her airway felt like it was closing; Could not focus; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was very painful and she could not lift it above her head), DIZZINESS (Felt like she was going to faint/Felt dizzy all day), FEELING ABNORMAL (Did not feel like herself), VERTIGO (Head was spinning in circles) and THROAT TIGHTNESS (Her airway felt like it was closing) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Since start of high school) and Allergy (Long standing). Concomitant products included TRIAMCINOLONE ACETONIDE (NASACORT) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and LEVALBUTEROL [LEVOSALBUTAMOL] for Asthma, VITAMINS NOS for General physical condition.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was very painful and she could not lift it above her head), DIZZINESS (Felt like she was going to faint/Felt dizzy all day), VERTIGO (Head was spinning in circles), THROAT TIGHTNESS (Her airway felt like it was closing), DISTURBANCE IN ATTENTION (Could not focus), NAUSEA (Felt nauseous) and CHILLS (Chills). On 21-Feb-2021, the patient experienced FEELING ABNORMAL (Did not feel like herself) and MALAISE (felt really sick). On 17-Mar-2021, the patient experienced ARTHRALGIA (arthralgia - sheets soaked in the morning). The patient was treated with PARACETAMOL (TYLENOL) (nasal) at a dose of 4 dosage form. On 18-Mar-2021, ARTHRALGIA (arthralgia - sheets soaked in the morning) had resolved. On 22-Mar-2021, PAIN IN EXTREMITY (Arm was very painful and she could not lift it above her head), DIZZINESS (Felt like she was going to faint/Felt dizzy all day), FEELING ABNORMAL (Did not feel like herself), VERTIGO (Head was spinning in circles), THROAT TIGHTNESS (Her airway felt like it was closing), DISTURBANCE IN ATTENTION (Could not focus), MALAISE (felt really sick), NAUSEA (Felt nauseous) and CHILLS (Chills) had resolved.            The treatment history was not provided. The Tylenol was given as 4 doses as inhalation was given.   This case was linked to MOD-2021-253324, MOD-2021-253324 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: follow up received on 12 -july-21, new events were mentioned with recovered dates are mentioned
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Throat tightness, Vaccination site pain, Vertigo
Clinical narrative: arthralgia - sheets soaked in the morning; Did not feel like herself; felt really sick; Felt nauseous; Chills; Vaccination site pain; Felt like she was going to faint/Felt dizzy all day; Head was spinning in circles; Her airway felt like it was closing; Could not focus; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was very painful and she could not lift it above her head), DIZZINESS (Felt like she was going to faint/Felt dizzy all day), FEELING ABNORMAL (Did not feel like herself), VERTIGO (Head was spinning in circles) and THROAT TIGHTNESS (Her airway felt like it was closing) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Since start of high school) and Allergy (Long standing). Concomitant products included TRIAMCINOLONE ACETONIDE (NASACORT) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and LEVALBUTEROL [LEVOSALBUTAMOL] for Asthma, VITAMINS NOS for General physical condition.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was very painful and she could not lift it above her head), DIZZINESS (Felt like she was going to faint/Felt dizzy all day), VERTIGO (Head was spinning in circles), THROAT TIGHTNESS (Her airway felt like it was closing), DISTURBANCE IN ATTENTION (Could not focus), NAUSEA (Felt nauseous) and CHILLS (Chills). On 21-Feb-2021, the patient experienced FEELING ABNORMAL (Did not feel like herself) and MALAISE (felt really sick). On 17-Mar-2021, the patient experienced ARTHRALGIA (arthralgia - sheets soaked in the morning). The patient was treated with PARACETAMOL (TYLENOL) (nasal) at a dose of 4 dosage form. On 18-Mar-2021, ARTHRALGIA (arthralgia - sheets soaked in the morning) had resolved. On 22-Mar-2021, PAIN IN EXTREMITY (Arm was very painful and she could not lift it above her head), DIZZINESS (Felt like she was going to faint/Felt dizzy all day), FEELING ABNORMAL (Did not feel like herself), VERTIGO (Head was spinning in circles), THROAT TIGHTNESS (Her airway felt like it was closing), DISTURBANCE IN ATTENTION (Could not focus), MALAISE (felt really sick), NAUSEA (Felt nauseous) and CHILLS (Chills) had resolved.            The treatment history was not provided. The Tylenol was given as 4 doses as inhalation was given.   This case was linked to MOD-2021-253324, MOD-2021-253324 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: follow up received on 12 -july-21, new events were mentioned with recovered dates are mentioned
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: red at the injection site; swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.    This case was linked to MOD21-035487 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Hot injection site; Itching at the injection site; Swelling at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot injection site), INJECTION SITE PRURITUS (Itching at the injection site), INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE ERYTHEMA (Redness at the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 015M20A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced INJECTION SITE WARMTH (Hot injection site), INJECTION SITE PRURITUS (Itching at the injection site), INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE ERYTHEMA (Redness at the injection site). At the time of the report, INJECTION SITE WARMTH (Hot injection site), INJECTION SITE PRURITUS (Itching at the injection site), INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Chills, Cough, Decreased appetite, Fatigue
Clinical narrative: has not eaten yet only drank a lot of fluids; cough; nausea; fatigue,feel tired; fever up to 100.8F; chills,; Since Friday night she has been experiencing symptoms that have been increasing; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), DECREASED APPETITE (has not eaten yet only drank a lot of fluids), COUGH (cough), NAUSEA (nausea) and FATIGUE (fatigue,feel tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EM9810) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Pain.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 19-Feb-2021, the patient experienced ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), COUGH (cough), NAUSEA (nausea), FATIGUE (fatigue,feel tired), PYREXIA (fever up to 100.8F) and CHILLS (chills,). On 22-Feb-2021, the patient experienced DECREASED APPETITE (has not eaten yet only drank a lot of fluids). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), DECREASED APPETITE (has not eaten yet only drank a lot of fluids), COUGH (cough), NAUSEA (nausea), FATIGUE (fatigue,feel tired), PYREXIA (fever up to 100.8F) and CHILLS (chills,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Pyrexia: 100.8 (High) 100.8F.         Treatment details included paracetamol and cough medicine. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: has not eaten yet only drank a lot of fluids; cough; nausea; fatigue,feel tired; fever up to 100.8F; chills,; Since Friday night she has been experiencing symptoms that have been increasing; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), DECREASED APPETITE (has not eaten yet only drank a lot of fluids), COUGH (cough), NAUSEA (nausea) and FATIGUE (fatigue,feel tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EM9810) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Pain.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 19-Feb-2021, the patient experienced ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), COUGH (cough), NAUSEA (nausea), FATIGUE (fatigue,feel tired), PYREXIA (fever up to 100.8F) and CHILLS (chills,). On 22-Feb-2021, the patient experienced DECREASED APPETITE (has not eaten yet only drank a lot of fluids). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), DECREASED APPETITE (has not eaten yet only drank a lot of fluids), COUGH (cough), NAUSEA (nausea), FATIGUE (fatigue,feel tired), PYREXIA (fever up to 100.8F) and CHILLS (chills,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Pyrexia: 100.8 (High) 100.8F.         Treatment details included paracetamol and cough medicine. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Burning at injection site/Burning on injected arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Burning at injection site/Burning on injected arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Burning at injection site/Burning on injected arm). At the time of the report, VACCINATION SITE PAIN (Burning at injection site/Burning on injected arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Patient received 2nd Moderna Vaccine ~28 days from 1st Vaccination and 2nd Vaccine did not hurt, had no symptoms.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Little pain in my arm; Pain with movement; I may have been more tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little pain in my arm), PAIN (Pain with movement) and FATIGUE (I may have been more tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A, 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little pain in my arm), PAIN (Pain with movement) and FATIGUE (I may have been more tired). At the time of the report, PAIN IN EXTREMITY (Little pain in my arm), PAIN (Pain with movement) and FATIGUE (I may have been more tired) outcome was unknown.            No concomitant medication was reported.  Treatment medication was not provided by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Confusional state, Dizziness, Gait disturbance, Injection site pain
Clinical narrative: feels off balance; felt discombobulated; can't walk right; feels dizzy; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (feels off balance), CONFUSIONAL STATE (felt discombobulated), GAIT DISTURBANCE (can't walk right), DIZZINESS (feels dizzy) and INJECTION SITE PAIN (sore arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CANNABIDIOL (CBD OIL), AMLODIPINE and BUSPIRONE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced BALANCE DISORDER (feels off balance), CONFUSIONAL STATE (felt discombobulated), GAIT DISTURBANCE (can't walk right), DIZZINESS (feels dizzy) and INJECTION SITE PAIN (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BALANCE DISORDER (feels off balance), CONFUSIONAL STATE (felt discombobulated), GAIT DISTURBANCE (can't walk right), DIZZINESS (feels dizzy) and INJECTION SITE PAIN (sore arm) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: My brother in law got 1st dose of moderna vaccine and 2 days later he got Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (My brother in law got 1st dose of moderna vaccine and 2 days later he got Covid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (My brother in law got 1st dose of moderna vaccine and 2 days later he got Covid). At the time of the report, COVID-19 (My brother in law got 1st dose of moderna vaccine and 2 days later he got Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Fatigue, Headache, Heart rate, Lymph node pain
Clinical narrative: arm soreness; lymph node soreness; itchiness at injection site; Severe headaches; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), LYMPH NODE PAIN (lymph node soreness), VACCINATION SITE PRURITUS (itchiness at injection site), HEADACHE (Severe headaches) and FATIGUE (exhaustion) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included Spinal stenosis in 1959, IBD and Uterine cancer (Survived uterine cancer years ago.). Concurrent medical conditions included Type 2 diabetes mellitus since December 2004, Bronchial asthma, Allergy to antibiotic, Seasonal allergy, Penicillin allergy, Latex allergy, Herpes simplex (erythema multiforme), TMJ syndrome (At 17 years) and Bladder cancer (remission) in 2019. Concomitant products included SIMVASTATIN, ATENOLOL, PARACETAMOL (TYLENOL), FAMOTIDINE (PEPCID [FAMOTIDINE]) and CURCUMA LONGA RHIZOME (TURMERIC CURCUMIN [CURCUMA LONGA RHIZOME]) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), LYMPH NODE PAIN (lymph node soreness), VACCINATION SITE PRURITUS (itchiness at injection site), HEADACHE (Severe headaches) and FATIGUE (exhaustion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness), LYMPH NODE PAIN (lymph node soreness) and HEADACHE (Severe headaches) had resolved and VACCINATION SITE PRURITUS (itchiness at injection site) and FATIGUE (exhaustion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Heart rate: unknown (High) Increased. On an unknown date, Electrocardiogram: unknown (abnormal) sinus rhythm.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up received on 28APR2021, updated patient demographics, past medical history, concomitant medications, treatment medication and events outcome as recovered.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus
Clinical narrative: arm soreness; lymph node soreness; itchiness at injection site; Severe headaches; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), LYMPH NODE PAIN (lymph node soreness), VACCINATION SITE PRURITUS (itchiness at injection site), HEADACHE (Severe headaches) and FATIGUE (exhaustion) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included Spinal stenosis in 1959, IBD and Uterine cancer (Survived uterine cancer years ago.). Concurrent medical conditions included Type 2 diabetes mellitus since December 2004, Bronchial asthma, Allergy to antibiotic, Seasonal allergy, Penicillin allergy, Latex allergy, Herpes simplex (erythema multiforme), TMJ syndrome (At 17 years) and Bladder cancer (remission) in 2019. Concomitant products included SIMVASTATIN, ATENOLOL, PARACETAMOL (TYLENOL), FAMOTIDINE (PEPCID [FAMOTIDINE]) and CURCUMA LONGA RHIZOME (TURMERIC CURCUMIN [CURCUMA LONGA RHIZOME]) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), LYMPH NODE PAIN (lymph node soreness), VACCINATION SITE PRURITUS (itchiness at injection site), HEADACHE (Severe headaches) and FATIGUE (exhaustion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness), LYMPH NODE PAIN (lymph node soreness) and HEADACHE (Severe headaches) had resolved and VACCINATION SITE PRURITUS (itchiness at injection site) and FATIGUE (exhaustion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Heart rate: unknown (High) Increased. On an unknown date, Electrocardiogram: unknown (abnormal) sinus rhythm.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up received on 28APR2021, updated patient demographics, past medical history, concomitant medications, treatment medication and events outcome as recovered.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Tenderness, Urticaria
Clinical narrative: rash warped into a large welt, which was 4 inches long and 3 inches wide; tenderness around the injection site; itchiness below the injection site; swelling below the injection site; rash at the injection site; headaches; mild fatigue; arm redness; This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (arm redness), URTICARIA (rash warped into a large welt, which was 4 inches long and 3 inches wide), TENDERNESS (tenderness around the injection site), VACCINATION SITE PRURITUS (itchiness below the injection site) and VACCINATION SITE SWELLING (swelling below the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ERYTHEMA (arm redness), TENDERNESS (tenderness around the injection site), VACCINATION SITE PRURITUS (itchiness below the injection site), VACCINATION SITE SWELLING (swelling below the injection site), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headaches) and FATIGUE (mild fatigue). On 19-Feb-2021, the patient experienced URTICARIA (rash warped into a large welt, which was 4 inches long and 3 inches wide). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (arm redness), URTICARIA (rash warped into a large welt, which was 4 inches long and 3 inches wide), TENDERNESS (tenderness around the injection site), VACCINATION SITE PRURITUS (itchiness below the injection site), VACCINATION SITE SWELLING (swelling below the injection site), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headaches) and FATIGUE (mild fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: rash warped into a large welt, which was 4 inches long and 3 inches wide; tenderness around the injection site; itchiness below the injection site; swelling below the injection site; rash at the injection site; headaches; mild fatigue; arm redness; This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (arm redness), URTICARIA (rash warped into a large welt, which was 4 inches long and 3 inches wide), TENDERNESS (tenderness around the injection site), VACCINATION SITE PRURITUS (itchiness below the injection site) and VACCINATION SITE SWELLING (swelling below the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ERYTHEMA (arm redness), TENDERNESS (tenderness around the injection site), VACCINATION SITE PRURITUS (itchiness below the injection site), VACCINATION SITE SWELLING (swelling below the injection site), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headaches) and FATIGUE (mild fatigue). On 19-Feb-2021, the patient experienced URTICARIA (rash warped into a large welt, which was 4 inches long and 3 inches wide). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (arm redness), URTICARIA (rash warped into a large welt, which was 4 inches long and 3 inches wide), TENDERNESS (tenderness around the injection site), VACCINATION SITE PRURITUS (itchiness below the injection site), VACCINATION SITE SWELLING (swelling below the injection site), VACCINATION SITE RASH (rash at the injection site), HEADACHE (headaches) and FATIGUE (mild fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: arm stiffness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (arm stiffness) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (arm stiffness). At the time of the report, MUSCULOSKELETAL STIFFNESS (arm stiffness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, SARS-CoV-2 test positive
Clinical narrative: Is still experiencing cough; Is still experiencing fatigue; Started getting symptoms of COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Started getting symptoms of COVID), COUGH (Is still experiencing cough) and FATIGUE (Is still experiencing fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (Started getting symptoms of COVID). On an unknown date, the patient experienced COUGH (Is still experiencing cough) and FATIGUE (Is still experiencing fatigue). At the time of the report, COVID-19 (Started getting symptoms of COVID), COUGH (Is still experiencing cough) and FATIGUE (Is still experiencing fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, SARS-CoV-2 test positive: positive (Positive) Patient  has been tested negative on 20Feb2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Hypertension and Blood pressure. Concomitant products included INSULIN for Diabetes, CYANOCOBALAMIN (VITAMIN B-12) and IBUPROFEN (ADVIL 12 HOUR) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph nodes on her neck (under her ear/jaw line) swelled up; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph nodes on her neck (under her ear/jaw line) swelled up) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes on her neck (under her ear/jaw line) swelled up). At the time of the report, LYMPHADENOPATHY (Lymph nodes on her neck (under her ear/jaw line) swelled up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medications Antibiotic
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Bedridden, Chills, Dizziness
Clinical narrative: headache; nausea; Extremely light headed; fatigued; Felt bedridden for 24 hours; weakness; chills; Body aches; Ankle pain; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), BEDRIDDEN (Felt bedridden for 24 hours), DIZZINESS (Extremely light headed), RASH (Rash) and ARTHRALGIA (Ankle pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Tylerol, Codiene). Concomitant products included LORATADINE (LORTADINE) for Allergy to animal, PARACETAMOL (TYLENOL) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced RASH (Rash). On 17-Feb-2021, the patient experienced ASTHENIA (weakness), ARTHRALGIA (Ankle pain), CHILLS (chills) and MYALGIA (Body aches). On 18-Feb-2021, the patient experienced BEDRIDDEN (Felt bedridden for 24 hours). On 21-Feb-2021, the patient experienced DIZZINESS (Extremely light headed) and FATIGUE (fatigued). On 22-Feb-2021, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, ASTHENIA (weakness), BEDRIDDEN (Felt bedridden for 24 hours), DIZZINESS (Extremely light headed), ARTHRALGIA (Ankle pain), FATIGUE (fatigued), HEADACHE (headache) and NAUSEA (nausea) was resolving and RASH (Rash), CHILLS (chills) and MYALGIA (Body aches) had resolved.            Treatment medication was Tylenol. Concomitant product use include Loratidine for the treatment of Cat allergy   This case was linked to MOD-2021-019906 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19-4-2021, patient information added, allergy added, concomitant product use added and events added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start  date of the event, a causal relationship cannot be excluded follow up received on 19 May 2021 included patient information allergy, concomitant product use and event rash, does not change company causality assessment and temporal relationship cannot be excluded.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Rash
Clinical narrative: headache; nausea; Extremely light headed; fatigued; Felt bedridden for 24 hours; weakness; chills; Body aches; Ankle pain; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), BEDRIDDEN (Felt bedridden for 24 hours), DIZZINESS (Extremely light headed), RASH (Rash) and ARTHRALGIA (Ankle pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Tylerol, Codiene). Concomitant products included LORATADINE (LORTADINE) for Allergy to animal, PARACETAMOL (TYLENOL) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced RASH (Rash). On 17-Feb-2021, the patient experienced ASTHENIA (weakness), ARTHRALGIA (Ankle pain), CHILLS (chills) and MYALGIA (Body aches). On 18-Feb-2021, the patient experienced BEDRIDDEN (Felt bedridden for 24 hours). On 21-Feb-2021, the patient experienced DIZZINESS (Extremely light headed) and FATIGUE (fatigued). On 22-Feb-2021, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, ASTHENIA (weakness), BEDRIDDEN (Felt bedridden for 24 hours), DIZZINESS (Extremely light headed), ARTHRALGIA (Ankle pain), FATIGUE (fatigued), HEADACHE (headache) and NAUSEA (nausea) was resolving and RASH (Rash), CHILLS (chills) and MYALGIA (Body aches) had resolved.            Treatment medication was Tylenol. Concomitant product use include Loratidine for the treatment of Cat allergy   This case was linked to MOD-2021-019906 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19-4-2021, patient information added, allergy added, concomitant product use added and events added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start  date of the event, a causal relationship cannot be excluded follow up received on 19 May 2021 included patient information allergy, concomitant product use and event rash, does not change company causality assessment and temporal relationship cannot be excluded.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Nausea, Palpitations
Clinical narrative: Out of breath; Had a fast heart beat for two hours; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Out of breath), PALPITATIONS (Had a fast heart beat for two hours) and NAUSEA (Nauseous) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Penicillin allergy and Drug allergy (allergic to Lipitor).    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced DYSPNOEA (Out of breath), PALPITATIONS (Had a fast heart beat for two hours) and NAUSEA (Nauseous). On 20-Feb-2021, DYSPNOEA (Out of breath), PALPITATIONS (Had a fast heart beat for two hours) and NAUSEA (Nauseous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain, Pyrexia
Clinical narrative: woke up with lots of soreness /body hurts; fatigue; temperature is 102.6degF /Tylenol is not reducing his temperature; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (woke up with lots of soreness /body hurts), FATIGUE (fatigue), PYREXIA (temperature is 102.6degF /Tylenol is not reducing his temperature) and MYALGIA (muscle aches) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 022M20A) for COVID-19 vaccination.     no medical history is provided and concomitant drugs are provided.  Concomitant products included INSULIN HUMAN (INSULIN RAPID), INSULIN HUMAN INJECTION, ISOPHANE (INSULIN N), METFORMIN, LOSARTAN, GLIPIZIDE and FISH OIL for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN (woke up with lots of soreness /body hurts), FATIGUE (fatigue), PYREXIA (temperature is 102.6degF /Tylenol is not reducing his temperature) and MYALGIA (muscle aches). At the time of the report, PAIN (woke up with lots of soreness /body hurts), FATIGUE (fatigue), PYREXIA (temperature is 102.6degF /Tylenol is not reducing his temperature) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to the touch; Itch; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (Redness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported. No treatment was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Contact information was updated, Patient First name, Address ,Email was updated.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Mobility decreased, Nasopharyngitis, Pain
Clinical narrative: Her arm is really achy, and she can't move; Her arm is really achy, and she can't move; aching all over but especially for her ankles and hands; experienced pain with her the outside of the leg on her left knee; feels like she is having a cold; feels cold and tired; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included Renal disease and Knee surgery NOS.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Her arm is really achy, and she can't move; Her arm is really achy, and she can't move; aching all over but especially for her ankles and hands; experienced pain with her the outside of the leg on her left knee; feels like she is having a cold; feels cold and tired; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included Renal disease and Knee surgery NOS.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.